First Time Loading...

Revolution Medicines Inc
NASDAQ:RVMD

Watchlist Manager
Revolution Medicines Inc Logo
Revolution Medicines Inc
NASDAQ:RVMD
Watchlist
Price: 38.95 USD -1.12%
Updated: May 16, 2024

Revolution Medicines Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Revolution Medicines Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Revolution Medicines Inc
NASDAQ:RVMD
Interest Income Expense
$47.2m
CAGR 3-Years
179%
CAGR 5-Years
135%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$757m
CAGR 3-Years
35%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Revolution Medicines Inc's Interest Income Expense?
Interest Income Expense
47.2m USD

Based on the financial report for Dec 31, 2023, Revolution Medicines Inc's Interest Income Expense amounts to 47.2m USD.

What is Revolution Medicines Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
135%

Over the last year, the Interest Income Expense growth was 416%. The average annual Interest Income Expense growth rates for Revolution Medicines Inc have been 179% over the past three years , 135% over the past five years .